Leveraging Gamma-Delta T Cells for the Control of Human Immunodeficiency Virus

EasyChair Preprint no. 12560

Abstract

Addressing the global health challenge posed by Human Immunodeficiency Virus (HIV) requires innovative strategies to combat the virus and enhance treatment outcomes. This study investigates the potential of gamma-delta (γδ) T cells in HIV management, with a specific focus on exploring lesser-known aspects of their functionality and untapped therapeutic potential. The article offers a comprehensive review of current literature concerning γδ T cells, emphasizing their unique characteristics and their role in bridging innate and adaptive immune responses. Additionally, the research delves into recent advancements in understanding the elusive traits of these cells and their potential impact on controlling HIV. The findings of this study suggest promising pathways for leveraging γδ T cells in ongoing endeavors to combat HIV.

Keyphrases: Gamma-Delta T Cells, Human Immunodeficiency Virus, Mouse and Rat Model

@Booklet{EasyChair:12560,
  author = {Isabella Rossi},
  title = {Leveraging Gamma-Delta T Cells for the Control of Human Immunodeficiency Virus},
  howpublished = {EasyChair Preprint no. 12560},

  year = {EasyChair, 2024}}